Sandra Prucka, MS, LCGC
Ms. Prucka is a board-certified genetic counselor and holds a license to practice genetic counseling in the state of Indiana. She is the Director of Genetic Counseling for Clinical Services at Indiana University School of Medicine where she is committed to providing access to genetic counseling services throughout the State. In this role she is responsible for leading the vision and strategic plan for provision of genetic counseling services and expansion into new areas at Indiana University School of Medicine and Indiana University Health Physicians. This includes developing outreach and educational efforts, which have recently included establishing telegenetic counseling services to better meet the genetic counseling needs of Indiana residents.
Ms. Prucka is also very active with external organizations and holds several leadership positions. She is currently a Board Member at Large with the Indiana Network of Genetic Counselors. She also serves as a co-chair for the National Society of Genetic Counselors Practice and Development Task Force that is part of the Leadership and Management Special Interest Group, and serves as an Advisory Board Member for Frontline Genomics. Ms. Prucka is an active participant in the Industry Pharmacogenomics working group, which is a national group comprised of functionally diverse members from pharmaceutical and biotechnology companies engaged in pre-competitively addressing emerging issues related to pharmacogenomics. Ms. Prucka co-chaired this group from 2015 – 2017 and led the Education and Communication Task Force from 2013 – 2017, a task force she is still actively engaged in.
Prior to joining Indiana University School of Medicine, Ms. Prucka worked in the Tailored Therapeutics Group (2009 – 2016) and Clinical Innovations Group (2016 – 2017) at Eli Lilly and Company. While at Lilly, Ms. Prucka completed a bioethics internship and served as an elected member of the National Society of Genetic Counselors Ethics Advisory Group (2014 – 2017). She was also an invited co-chair for a working group with the Harvard Multi-Regional Clinical Trials Group focused on generating a guidance document and toolkit regarding the return of individual research results generated from participation in medical research (2015 – 2017). Ms Prucka also served on the Innovative Medicines Initiative Big Data for Better Outcomes Coordination and Support Action for Data Privacy (2015 – 2017). Prior to working at Lilly Ms. Prucka was the Director of Genetic Counseling Clinical Services for the University of Alabama at Birmingham where she also saw patients in a variety of clinical settings (2003 – 2008).
Ms. Prucka received a Master’s of Science in Genetic Counseling from the University of Pittsburgh Department of Human Genetics, Pittsburgh, PA in 2003. She received a Bachelor of Science Degree in Cellular and Molecular Biology from the University of Michigan, Ann Arbor, MI in 2000.